| Abstract PO2-15-10: Identifying new immune-related biomarkers in TNBC with a look at PD-L1 cell-autonomous role C Costa, C von Arx, A Calabrese, F Pentimalli, M Luciano, A Giordano, ... Cancer Research 84 (9_Supplement), PO2-15-10-PO2-15-10, 2024 | | 2024 |
| Mesothelioma Associated Fibroblasts Modulate the Response of Mesothelioma Patient Derived Organoids to Chemotherapy through Interleukin-6. M Cioce, V Gatti, F Napolitano, NM Giorgiano, A Marra, G Portella, ... Preprints, 2024 | | 2024 |
| Immunotherapy as first-line treatment in locally advanced/metastatic and previously untreated squamous cell lung cancer: which advances? NM Giorgiano, F Pentimalli, G Natale, CM Della Corte, F Morgillo, ... AME Clinical Trials Review, 2024 | | 2024 |
| Multiple aspects of matrix stiffness in cancer progression A Mancini, MT Gentile, F Pentimalli, S Cortellino, M Grieco, A Giordano | | 2024 |
| “Could Patient Age and Gender, along with Mass Size, Be Predictive Factors for Benign Kidney Tumors?”: A Retrospective Analysis of 307 Consecutive Single Renal Masses Treated … R Baio, G Molisso, C Caruana, U Di Mauro, O Intilla, U Pane, C D’Angelo, ... Bioengineering 10 (7), 794, 2023 | 1 | 2023 |
| The Role of FBXW7 in Gynecologic Malignancies R Di Fiore, S Suleiman, R Drago-Ferrante, Y Subbannayya, S Suleiman, ... Cells 12 (10), 1415, 2023 | 4 | 2023 |
| Apoptotic cell death in disease—Current understanding of the NCCD 2023 I Vitale, F Pietrocola, E Guilbaud, SA Aaronson, JM Abrams, D Adam, ... Cell Death & Differentiation, 1-58, 2023 | 113 | 2023 |
| Synchronous bladder and prostate cancer specimens obtained from radical cystoprostatectomy: A single‑center retrospective analysis R Baio, G Molisso, C Caruana, U Di Mauro, O Intilla, U Pane, C D'angelo, ... Experimental and Therapeutic Medicine 25 (4), 1-7, 2023 | 2 | 2023 |
| “To Be or Not to Be Benign” at Partial Nephrectomy for Presumed RCC Renal Masses: Single-Center Experience with 195 Consecutive Patients R Baio, G Molisso, C Caruana, U Di Mauro, O Intilla, U Pane, C D’Angelo, ... Diseases 11 (1), 27, 2023 | 5 | 2023 |
| Intratumor microbiota as a novel potential prognostic indicator in mesothelioma F Pentimalli, M Krstic-Demonacos, C Costa, L Mutti, EY Bakker Frontiers in Immunology 14, 2023 | 4 | 2023 |
| Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology T Meirson, V Nardone, F Pentimalli, G Markel, D Bomze, M D’Apolito, ... Journal of Translational Medicine 20 (1), 1-9, 2022 | 6 | 2022 |
| Association between obesity and frequency of high‑grade prostate cancer on biopsy in men: A single‑center retrospective study R Baio, G Napodano, C Caruana, G Molisso, U Di Mauro, O Intilla, ... Molecular and Clinical Oncology 17 (2), 1-11, 2022 | 12 | 2022 |
| Medical and surgical care of patients with mesothelioma and their relatives carrying germline BAP1 mutations M Carbone, HI Pass, G Ak, HR Alexander Jr, P Baas, F Baumann, ... Journal of Thoracic Oncology 17 (7), 873-889, 2022 | 64 | 2022 |
| Incidence rate and management of diaphragmatic injury during laparoscopic nephrectomies: single-center experience R Baio, G Molisso, C Caruana, O Intilla, U Di Mauro, U Pane, A Campitelli, ... Journal of Surgical Case Reports 2022 (6), rjac127, 2022 | 3 | 2022 |
| Pharmacological reactivation of RBL2/p130 could be an effective antitumoral strategy for malignant pleural mesothelioma A Costa, IM Forte, E Ventura, F Pentimalli, A Giordano The FASEB Journal 36, 2022 | | 2022 |
| Medical and surgical care of mesothelioma patients and their relatives carrying germline BAP1 mutations M Carbone, HI Pass, G Ak, HR Alexander Jr, P Baas, F Baumann, ... Journal of Thoracic Oncology, 2022 | | 2022 |
| Comparison of 3 randomized clinical trials of frontline therapies for malignant pleural mesothelioma T Meirson, F Pentimalli, F Cerza, G Baglio, SG Gray, P Correale, ... JAMA network open 5 (3), e221490-e221490, 2022 | 37 | 2022 |
| Association between obesity and frequency of high-grade prostate cancer on biopsy in men: A single-center retrospective study G Napodano, C Caruana, G Molisso, U Di Mauro, O Intilla, U Pane, ... Molecular and Clinical Oncology 17 (2), 2022 | | 2022 |
| The Emerging Role of Cyclin-Dependent Kinase Inhibitors in Treating Diet-Induced Obesity: New Opportunities for Breast and Ovarian Cancers? R Benot-Dominguez, A Cimini, D Barone, A Giordano, F Pentimalli Cancers 14 (11), 2709, 2022 | 5 | 2022 |
| Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review R Di Fiore, S Suleiman, R Drago-Ferrante, Y Subbannayya, F Pentimalli, ... International Journal of Molecular Sciences 23 (9), 5167, 2022 | 29 | 2022 |
